• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mismatch negativity: A simple and useful biomarker of N-methyl-d-aspartate receptor (NMDAR)-type glutamate dysfunction in schizophrenia.

作者信息

Avissar Michael, Javitt Daniel

机构信息

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, United States.

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, United States; Program in Cognitive Neuroscience and Schizophrenia, Nathan Kline Institute, Orangeburg, NY, United States.

出版信息

Schizophr Res. 2018 Jan;191:1-4. doi: 10.1016/j.schres.2017.11.006. Epub 2017 Nov 11.

DOI:10.1016/j.schres.2017.11.006
PMID:29132813
Abstract
摘要

相似文献

1
Mismatch negativity: A simple and useful biomarker of N-methyl-d-aspartate receptor (NMDAR)-type glutamate dysfunction in schizophrenia.失配负波：精神分裂症中N-甲基-D-天冬氨酸受体（NMDAR）型谷氨酸功能障碍的一种简单且有用的生物标志物。
Schizophr Res. 2018 Jan;191:1-4. doi: 10.1016/j.schres.2017.11.006. Epub 2017 Nov 11.
2
Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia.精神分裂症中失配负波功能障碍的皮质内机制
Audiol Neurootol. 2000 May-Aug;5(3-4):207-15. doi: 10.1159/000013882.
3
Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.谷氨酸与精神分裂症：苯环己哌啶、N-甲基-D-天冬氨酸受体及多巴胺-谷氨酸相互作用
Int Rev Neurobiol. 2007;78:69-108. doi: 10.1016/S0074-7742(06)78003-5.
4
[NMDA-type glutamate receptor and schizophrenia].[N-甲基-D-天冬氨酸型谷氨酸受体与精神分裂症]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2013 Nov;33(5-6):217-24.
5
Glutamate hypothesis in schizophrenia.精神分裂症的谷氨酸假说。
Psychiatry Clin Neurosci. 2019 May;73(5):204-215. doi: 10.1111/pcn.12823. Epub 2019 Mar 6.
6
Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.精神分裂症中海马 theta 波段振荡功能障碍的错配负波生物标志物。
Schizophr Res. 2018 Jan;191:51-60. doi: 10.1016/j.schres.2017.06.023. Epub 2017 Jun 28.
7
A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction.谷氨酸在精神分裂症发病机制及其认知功能障碍中起关键作用。
Pharmacol Biochem Behav. 1997 Apr;56(4):797-802. doi: 10.1016/s0091-3057(96)00428-5.
8
The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: On the path from syndrome to disease.精神分裂症的谷氨酸/N-甲基-D-天冬氨酸受体（NMDAR）模型35年回顾：从综合征到疾病的历程
Schizophr Res. 2022 Apr;242:56-61. doi: 10.1016/j.schres.2022.01.013. Epub 2022 Feb 4.
9
Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.精神分裂症动物模型：反复给予苯环利定后停药的小鼠中NMDA受体信号传导功能障碍。
Ann N Y Acad Sci. 2006 Nov;1086:160-8. doi: 10.1196/annals.1377.003.
10
Bringing order to the glutamate chaos in schizophrenia.梳理精神分裂症中谷氨酸紊乱的状况。
Neuron. 2003 Dec 4;40(5):881-4. doi: 10.1016/s0896-6273(03)00757-8.

引用本文的文献

1
Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia.错配负波（MMN）作为精神分裂症 NMDA 受体和兴奋性/抑制性失衡靶向治疗的药效学/反应生物标志物。
Adv Neurobiol. 2024;40:411-451. doi: 10.1007/978-3-031-69491-2_15.
2
Interaction between BDNF Val66Met polymorphism and mismatch negativity for working memory capacity in schizophrenia.脑源性神经营养因子Val66Met多态性与精神分裂症工作记忆容量失配负波之间的相互作用
Schizophrenia (Heidelb). 2024 Aug 22;10(1):70. doi: 10.1038/s41537-024-00493-x.
3
Drug Development for New Psychiatric Drug Therapies.
新型精神类药物治疗的药物研发。
Adv Neurobiol. 2023;30:131-167. doi: 10.1007/978-3-031-21054-9_5.
4
The effect of schizophrenia risk factors on mismatch responses in a rat model.精神分裂症风险因素对大鼠模型中失配响应的影响。
Psychophysiology. 2023 Feb;60(2):e14175. doi: 10.1111/psyp.14175. Epub 2022 Sep 10.
5
Decoding violated sensory expectations from the auditory cortex of anaesthetised mice: Hierarchical recurrent neural network depicts separate 'danger' and 'safety' units.从麻醉小鼠的听觉皮层解码违反感觉预期：分层递归神经网络描绘了单独的“危险”和“安全”单元。
Eur J Neurosci. 2022 Aug;56(3):4154-4175. doi: 10.1111/ejn.15736. Epub 2022 Jun 22.
6
Acute effects of Δ-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity.Δ-四氢大麻酚和大麻二酚对听觉失配负波的急性效应。
Psychopharmacology (Berl). 2022 May;239(5):1409-1424. doi: 10.1007/s00213-021-05997-3. Epub 2021 Nov 1.
7
Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling.与精神分裂症相关的 SLC39A8 多态性是一种功能丧失的等位基因，可改变谷氨酸受体和先天免疫信号。
Transl Psychiatry. 2021 Feb 19;11(1):136. doi: 10.1038/s41398-021-01262-5.
8
Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia.精神分裂症临床高危受试者空间位置的前注意加工缺陷与阴性症状
Front Psychiatry. 2021 Feb 2;11:629144. doi: 10.3389/fpsyt.2020.629144. eCollection 2020.
9
Potential Roles of Redox Dysregulation in the Development of Schizophrenia.氧化还原失调在精神分裂症发展中的潜在作用。
Biol Psychiatry. 2020 Aug 15;88(4):326-336. doi: 10.1016/j.biopsych.2020.03.016. Epub 2020 Apr 2.
10
A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology.神经振荡作为神经精神药理学治疗开发中转译生物标志物的发展路线图。
Neuropsychopharmacology. 2020 Aug;45(9):1411-1422. doi: 10.1038/s41386-020-0697-9. Epub 2020 May 6.